FDA
-
-
-
-
-
-
-
Novo Nordisk gets FDA fast track status for ATTR heart disease drug
-
-
-
-
-
-
-
FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile
-
-
-
-
-
-
-
FDA issues 30 warning letters to telehealth firms over GLP-1 claims
-
-
-
-
-
-
-
TD Cowen: 'Good News for Novo Nordisk (NVO), but Impact Uncertain'
-
-
-
-
-
-
-
Novo shares rebound as FDA vows crackdown on weight-loss drug copies
-
-
-
-
-
-
-
Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight-loss pill
-
-
-
-
-
-
-
Novo Nordisk's Wegovy pill wins FDA approval as first oral GLP-1 for weight loss
-
322,883 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

